Arcutis Biotherapeutics, Inc. (ARQT)

NASDAQ: ARQT · Real-Time Price · USD

20.86

-0.15 (-0.71%)

At close: May 22, 2026, 4:00 PM EDT

20.56

-0.30 (-1.42%)

After-hours: May 22, 2026, 7:52 PM EDT

Arcutis Biotherapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 22, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	2,609	3,582	1,642	313	903	1,042
Market Cap Growth	61.96%	118.17%	425.11%	-65.39%	-13.33%	-14.50%
Enterprise Value	2,500	3,474	1,523	245.02	694.42	730.82
Last Close Price	20.86	29.04	13.93	3.23	14.80	20.74
Forward PE	69.53	76.62	-	-	-	-
PS Ratio	6.28	9.52	8.35	5.24	245.08	-
PB Ratio	13.75	18.90	10.42	3.53	4.31	3.50
P/TBV Ratio	14.43	19.50	10.70	2.53	3.89	3.44
EV/Sales Ratio	6.01	9.24	7.75	4.11	188.39	-
Debt / Equity Ratio	0.56	0.60	0.70	2.31	0.96	0.26
Debt / EBITDA Ratio	20.99	-	-	-	-	-
Debt / FCF Ratio	4.26	-	-	-	-	-
Net Debt / Equity Ratio	-0.58	-0.56	-0.75	-0.75	-0.99	-1.04
Net Debt / EBITDA Ratio	-20.07	14.16	0.94	0.28	0.69	1.51
Net Debt / FCF Ratio	-4.07	16.97	1.06	0.27	0.81	1.77
Asset Turnover	0.93	0.96	0.57	0.15	0.01	0
Inventory Turnover	1.25	1.97	1.38	0.48	0.20	-
Quick Ratio	2.26	2.83	3.72	6.40	11.09	11.66
Current Ratio	2.68	3.17	4.15	7.08	11.57	12.09
Return on Equity (ROE)	-1.25%	-9.30%	-113.76%	-175.79%	-122.80%	-72.62%
Return on Assets (ROA)	1.23%	-3.37%	-37.38%	-61.72%	-70.36%	-58.47%
Return on Invested Capital (ROIC)	6.72%	-21.59%	-416.44%	-2037.82%	5010.00%	1745.95%
Return on Capital Employed (ROCE)	1.07%	-4.28%	-45.65%	-68.28%	-76.72%	-63.50%
Buyback Yield / Dilution	-2.70%	-5.19%	-74.53%	-25.94%	-11.39%	-38.51%
Total Shareholder Return	-2.70%	-5.19%	-74.53%	-25.94%	-11.39%	-38.51%

Updated May 6, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q